Depleting PPP1R26 by shRNA significantly decreased 18F-FDG accumulation in the xenografts derived from HCC cells, demonstrating that targeting PPP1R26 reduces glucose uptake and metabolism in vivo. The gene discussed is PPP1R26; the disease is hepatocellular carcinoma.